| Lung Squamous Cell Carcinoma altered in cohorts of …ALTERED_INderived200 of 321show all (up to 200) |
|---|
| ← altered in cohorts of | TP53 453 / 504 cases (90 %) · ssm · TCGA-LUSC · largest of 7 cohorts | — | — | Lung Squamous Cell Carcinoma | 7 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCC5 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP11B 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC39 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DVL3 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1AKMT4-ECE2 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPHB3 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL6 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCF3 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTRT3 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRD 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLCN2 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCUN1D1 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF2B5 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FNDC3B 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3C 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3E 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAGEF1 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP6D1 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MECOM 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PARL 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOX2 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNIK 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VPS8 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBBX 443 / 504 cases (88 %) · ssm · TCGA-LUSC · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | AP2M1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C3orf70 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4G1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM131A 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FXR1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GHSR 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL24 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMP3 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MB21D2 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCCC1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCF2L2 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLGN1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHC3 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3CA 442 / 504 cases (88 %) · ssm · TCGA-LUSC · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMD7 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA16 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THPO 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC14 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP13 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR49 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YEATS2 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALG3 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A5 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | B3GNT5 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAMK2N2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN11 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAJC19 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ECE2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ECT2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1AKMT4 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3D 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNMB2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC31 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRIQ4 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MASP1 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAALADL2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCEH1 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | P3H2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POLR2H 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKCI 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSMD2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SI 441 / 504 cases (88 %) · ssm · TCGA-LUSC · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC2A2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC7A14 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFSF10 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VWA5B2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF5A2 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR160 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC34 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYNN 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD1 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL22L1 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC62 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SKIL 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM212 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EHHADH 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETV5 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGF12 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGF2BP2 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP3K13 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PEX5L 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLAAT1 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SERPINI1 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM41A 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP63 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMAT3 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTL6A 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN1 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLG1 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPH 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC15 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBL1XR1 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 345 / 484 cases (71 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 209 / 484 cases (43 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 192 / 484 cases (40 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 188 / 484 cases (39 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 171 / 484 cases (35 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 160 / 484 cases (33 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 151 / 484 cases (31 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAM6 53 / 178 cases (30 %) · ssm · lusc_tcga | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 143 / 484 cases (30 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM135B 118 / 484 cases (24 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 111 / 484 cases (23 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 24 / 110 cases (22 %) · ssm · lusc_cptac_gdc · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NAV3 104 / 484 cases (21 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 99 / 484 cases (20 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH10 97 / 484 cases (20 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 97 / 484 cases (20 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 95 / 484 cases (20 %) · ssm · lusc_tcga_gdc · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 93 / 484 cases (19 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 93 / 484 cases (19 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 91 / 484 cases (19 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1 90 / 484 cases (19 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 20 / 108 cases (19 %) · ssm · lusc_cptac_2021 | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 20 / 108 cases (19 %) · ssm · lusc_cptac_2021 | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAPPA2 89 / 484 cases (18 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRTM3 20 / 110 cases (18 %) · ssm · lusc_cptac_gdc | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC19 20 / 110 cases (18 %) · ssm · lusc_cptac_gdc | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 88 / 484 cases (18 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 84 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 84 / 484 cases (17 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERICH3 84 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 84 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL22A1 83 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 83 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 82 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 82 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WHR1 30 / 178 cases (17 %) · ssm · lusc_tcga | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAMTS12 81 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 80 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 80 / 484 cases (17 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 79 / 484 cases (16 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTNAP5 78 / 484 cases (16 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HCN1 78 / 484 cases (16 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RELN 78 / 484 cases (16 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 77 / 484 cases (16 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 77 / 484 cases (16 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRB3 76 / 484 cases (16 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 73 / 484 cases (15 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDKN2A 73 / 484 cases (15 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH11X 73 / 484 cases (15 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNR 73 / 484 cases (15 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NFE2L2 72 / 484 cases (15 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 71 / 484 cases (15 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 71 / 484 cases (15 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 70 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FMN2 70 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRDM9 70 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804A 70 / 484 cases (14 %) · ssm · lusc_tcga_gdc · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 69 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 69 / 484 cases (14 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TPTE 69 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 69 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 68 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 68 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRINP3 67 / 484 cases (14 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA2 66 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK2 65 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 65 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLXNA4 65 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 64 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF536 64 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRC7 63 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 62 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRK2 62 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 62 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PEG3 62 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 60 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH18 60 / 484 cases (12 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CTNNA2 60 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH1 60 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH2 60 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN1A 60 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNN 60 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFAP61 22 / 178 cases (12 %) · ssm · lusc_tcga_pub · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 22 / 178 cases (12 %) · ssm · lusc_tcga_pub | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYCBP2 22 / 178 cases (12 %) · ssm · lusc_tcga_pub · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN2A 59 / 484 cases (12 %) · ssm · lusc_tcga_gdc · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM1 59 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | THSD7B 59 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 59 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 58 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTNAP2 58 / 484 cases (12 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN3 21 / 178 cases (12 %) · ssm · lusc_tcga_pub | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FN1 21 / 178 cases (12 %) · ssm · lusc_tcga_pub | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HRNR 21 / 178 cases (12 %) · ssm · lusc_tcga_pub · largest of 2 cohorts | — | — | Lung Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 21 / 178 cases (12 %) · ssm · lusc_tcga_pub | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MROH2B 57 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PDE4DIP 57 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL12A1 56 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 56 / 484 cases (12 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 56 / 484 cases (12 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MRC1 56 / 484 cases (12 %) · ssm · lusc_tcga_gdc | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 56 / 484 cases (12 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAMTS20 55 / 484 cases (11 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |